Genitourinary Cancer

COVID-19 Adversely Affecting Patients With Genitourinary Cancers

By

Jody A. Charnow

Publish Date February 17, 2021

In an online survey, 17.2% of patients with genitourinary cancers reported they delayed or avoided seeking medical care because of the COVID-19 pandemic.

Tumor Mutational Burden, Immune-Related Adverse Events in Metastatic Urothelial Cancer

By

Vicki Moore, PhD

Publish Date February 13, 2021

Researchers analyzed data from patients with metastatic urothelial cancer to determine whether tumor mutation burden was associated with immune-related AEs among patients treated with immune checkpoint inhibitors.

Survival Trends Analysis Shows Significant OS Gains for MIBC, But Not Urothelial Carcinoma

By

Leah Lawrence

Publish Date February 12, 2021

Investigators of this real-world analysis studied survival trends among patients with muscle-invasive bladder cancer (MIBC) and patients with metastatic urothelial carcinoma (UC).

Adjuvant Nivolumab Improves DFS in MIUC After Radical Surgery

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date February 12, 2021

CheckMate 274 investigators compared adjuvant nivolumab with placebo (PBO) in patients with MIUC who received cisplatin prior to radical surgery.

Cytoreductive Surgery May Have a Role in Treating Metastatic UTUC

By

Jody A. Charnow

Publish Date February 1, 2021

A study of patients with metastatic upper tract urothelial carcinoma demonstrated that those who underwent cytoreductive surgery after chemotherapy had significantly improved survival compared with those who received chemotherapy alone.